Portal Instruments to Present at Sixth Annual PODD Conference

Portal Instruments will present at the 2016 Partnership Opportunities in Drug Delivery (PODD) conference, a strategic level program for pharma and biotech business development professionals on the latest drug delivery technologies available.

Read More

bloomberg businessweek

Portal Instruments Featured in Bloomberg Businessweek

The Bloomberg Businessweek article “Ditching the Needle for a Less Painful Injection” describes the Portal technology, its intended use, and highlights its competitive advantage over other needle-free technologies.

Read More

redherring 100 winner

Portal Instruments Selected as a 2016 Red Herring Top 100 North America Winner

Red Herring North America announced Portal Instruments as one of its Top 100 award winners in recognition for being one of the leading private companies in the region.

Read More


Nature Features Portal Instruments in MedTech Dealmakers’ Quarterly Magazine

Nature features Portal Instruments in MedTech Dealmakers’ Quarterly Magazine, highlighting Portal’s transformative technology and partnership strategy.

Read More

Drug Delivery Partnerships

Portal Instruments Receives Company On the Rise Award at Drug Delivery Partnerships Annual Meeting

Portal Instruments receives “On the Rise Company” award, recognized by a panel of industry leaders and executives attending the 2016 Drug Delivery Partnerships annual meeting in Palm Beach Gardens, Florida.

Read More

Bio Investor Forum

Portal Presents at the 14th Annual BIO Investor Forum

With a unique focus on venture-stage growth and emerging public companies, the BIO Investor Forum offers an excellent opportunity for potential partnerships and business collaborations between over 360 biotech companies and the over 120 participating investors.

Read More

5 AM Ventures

Portal Instruments Closes a $25 Million Series B Financing to Commercialize its Transformative Needle-Free Drug Delivery System

Portal Instruments announced today that it closed a financing for $25 million of its Series B Preferred Stock led by 5AM Ventures and joined by Portal’s existing private and strategic investors, including Sanofi Sunrise.

Read More

Sanofi Sunrise Logo

Portal Instruments Completes Landmark $11 Million Series A Financing to Develop Innovative Drug Delivery Platform

Proceeds from the $11 million Series A financing will be used to develop Portal’s groundbreaking computerized needle-free drug delivery system ideally suited for administering viscous biologics and other formulations.

Read More

Portal Instruments needle free device

Portal Instruments Adds Two Esteemed Biotechnology Leaders to its Scientific Advisory Board

Portal Instruments announced today that Robert Langer, Sc.D., MIT Institute Professor, and Peter Hunter, Ph.D., University of Auckland Distinguished Professor have joined the company’s Scientific Advisory Board.

Read More

MF Management Forum

Portal Presents at the 2015 Injectable Drug Delivery Conference

The conference showcased established and rising industry leaders, who shed light on the latest self-injection trends, recent changes in the medical device regulatory space, the role connectivity is playing in the injector space, and the interplay of human factors considerations and device requirements.

Read More